88 related articles for article (PubMed ID: 23351312)
1. Getting personal: the promises and potential pitfalls of personalized medicine.
Ozer BH
Virtual Mentor; 2012 Aug; 14(8):601-3. PubMed ID: 23351312
[No Abstract] [Full Text] [Related]
2. Translational discoveries, personalized medicine, and living biobanks of the future.
Lisanti MP; Tanowitz HB
Am J Pathol; 2012 Apr; 180(4):1334-6. PubMed ID: 22453029
[No Abstract] [Full Text] [Related]
3. Getting personal: the promises and pitfalls of personalized medicine.
Laurence J
Transl Res; 2009 Dec; 154(6):269-71. PubMed ID: 19931191
[No Abstract] [Full Text] [Related]
4. The ethical framing of personalized medicine.
Joly Y; Saulnier KM; Osien G; Knoppers BM
Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):404-8. PubMed ID: 25054830
[TBL] [Abstract][Full Text] [Related]
5. Without an adequate ethical infrastructure, the road to personalized medicine will be rocky at best.
Caplan AL
Clin Pharmacol Ther; 2012 Oct; 92(4):411-2. PubMed ID: 22992666
[TBL] [Abstract][Full Text] [Related]
6. Personalized medicine: the road ahead.
Sznajder JI; Ciechanover A
Am J Respir Crit Care Med; 2012 Nov; 186(10):945-7. PubMed ID: 23155214
[No Abstract] [Full Text] [Related]
7. [Personalized or person-centered medicine? Their synthesis in an integrative and personalized healthcare supply].
Neugebauer E; Heusser P
Gesundheitswesen; 2014 Nov; 76(11):694-5. PubMed ID: 25462618
[No Abstract] [Full Text] [Related]
8. Infectious diseases biobanking as a catalyst towards personalized medicine: Mycobacterium tuberculosis paradigm.
Betsou F; Parida SK; Guillerm M
Tuberculosis (Edinb); 2011 Nov; 91(6):524-32. PubMed ID: 21855413
[TBL] [Abstract][Full Text] [Related]
9. [Ethical review of biobanks in The Netherlands: lessons from the String of Pearls Initiative].
Boeckhout M; van Dijk J; Legemate DA
Ned Tijdschr Geneeskd; 2011; 155(26):A3557. PubMed ID: 21767425
[TBL] [Abstract][Full Text] [Related]
10. Getting personal. Advances in biotechnology and the promise of personalized medicine help drive record investment in 2009.
Vesely R
Mod Healthc; 2010 Feb; 40(5):26-8. PubMed ID: 20198737
[No Abstract] [Full Text] [Related]
11. Personalized medicine for individuals with Down syndrome.
McCabe LL; McCabe ER
Mol Genet Metab; 2011; 104(1-2):7-9. PubMed ID: 21807541
[TBL] [Abstract][Full Text] [Related]
12. Regulation and the fate of personalized medicine.
Greenbaum D
Virtual Mentor; 2012 Aug; 14(8):645-52. PubMed ID: 23351321
[No Abstract] [Full Text] [Related]
13. A description and qualitative assessment of a 4-year intervention to improve patient counseling by improving medical student health.
Frank E; Smith D; Fitzmaurice D
MedGenMed; 2005 May; 7(2):4. PubMed ID: 16369383
[TBL] [Abstract][Full Text] [Related]
14. Informed consent for biobank-dependent research.
Botkin JR
Virtual Mentor; 2012 Aug; 14(8):610-5. PubMed ID: 23351314
[No Abstract] [Full Text] [Related]
15. Personalized medicine: medicine for the privileged?
Helft PR
Oncology (Williston Park); 2012 Sep; 26(9):814. PubMed ID: 23061334
[No Abstract] [Full Text] [Related]
16. Public Health Genomics and personalized healthcare: a pipeline from cell to society.
Brand A
Drug Metabol Drug Interact; 2012; 27(3):121-3. PubMed ID: 23104820
[No Abstract] [Full Text] [Related]
17. Biobanking: the foundation of personalized medicine.
Hewitt RE
Curr Opin Oncol; 2011 Jan; 23(1):112-9. PubMed ID: 21076300
[TBL] [Abstract][Full Text] [Related]
18. Genetic profiling of medical students.
Mahoney J
Virtual Mentor; 2012 Aug; 14(8):616-21. PubMed ID: 23351315
[No Abstract] [Full Text] [Related]
19. Group-based and personalized care in an age of genomic and evidence-based medicine: a reappraisal.
Maglo KN
Perspect Biol Med; 2012; 55(1):137-54. PubMed ID: 22643722
[TBL] [Abstract][Full Text] [Related]
20. Will personalized medicine challenge or reify categories of race and ethnicity?
Rajagopalan R; Fujimura JH
Virtual Mentor; 2012 Aug; 14(8):657-63. PubMed ID: 23351323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
